7 results
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Replacement - Anticoagulation ... anticoagulants (DOACs ... #Management #Cardiology ... #INR #Target #DOAC ... #Table #Replacement
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... anticoagulants (DOACs ... #Cancer #Algorithm ... #Anticoagulation ... #Management #Hematology
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
Causes of Breakthrough ... /Extension of Thrombosis ... and Management ... Algorithm #Anticoagulation ... #VTE #DVT #Hematology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
catheter-related thrombosis ... DOAC, direct oral ... #DOAC #VTE #Malignancy ... #Anticoagulation ... #Management #Hematology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
Over-anticoagulation ... can result in thrombosis ... #management #algorithm ... #medications #table ... decisionaid #cardiology #hematology
Peripartum Cardiomyopathy - Summary
1. Definition
 • Towards the end of pregnancy to 5 months postpartum
exclude other causes ... Avoid Warfarin and DOAC ... Delivery • Stable ... consensus on risk vs ... suggest prophylactic anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... • Treatment algorithms ... Hydroxyurea + anticoagulation ... #diagnosis #management ... #hematology